Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Disulfiram With Copper in Metastatic Breast Cancer
NCT03323346Phase 2Completed
- Sponsor
- Institute of Molecular and Translational Medicine
- Start
- Sep 2017
- Primary completion
- Oct 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of disulfiram in breast cancer, sponsored by Institute of Molecular and Translational Medicine. Started Sep 2017; status: completed.
02
Drugs
disulfiram
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT03323346.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03323346.